The British drug regulator urges people to continue taking the AstraZeneca coronavirus vaccine, despite news that seven people in the UK have died of a rare blood clot after being stabbed.
The U.S. Medical and Healthcare Regulatory Agency (MHRA) said that it is not yet clear whether these injections caused blood clots and that “the UK’s reports of rare and specific types of blood clots are under rigorous review.”
Although the agency said late Friday that seven people had died from blood clotting, it did not disclose any information about their age or health.
MHRA said that as of March 24, including March 24, a total of 30 rare blood clot events have been identified from 1
The agency’s chief executive, Dr. June Raine, said: “The benefits of the COVID-19 vaccine AstraZeneca in preventing COVID-19 infection and its complications continue to outweigh any risks. The public should continue to vaccinate when invited. vaccine.”
Concerns about the AstraZeneca vaccine have prompted countries including Canada, France, Germany and the Netherlands to restrict its use to the elderly.
The UK has launched a coronavirus vaccine faster than other European countries, and is particularly dependent on the AstraZeneca vaccine developed by scientists at the University of Oxford. The company has also been using vaccines developed by Pfizer-BioNTech, and the agency has not seen any reports of thrombotic events.
Data on Saturday showed that the United Kingdom has provided its first dose of vaccine to 31.4 million people (about 46% of its population), much higher than the rest of Europe. The focus of work in April was to provide a second dose, and 5.2 million people have now received two jabs.
The UK’s vaccination program has been relatively successful because it helped to significantly reduce the number of new coronavirus infections in the UK after the winter surge, paving the way for the moderate relaxation of blockade restrictions on gatherings.
On Saturday, the UK recorded another 3,423 infections, slightly higher than the six-month low of 3,402 the day before. It also recorded only 10 coronavirus-related deaths, which is the lowest daily total since the beginning of September.
Despite the improvement in the background of the coronavirus, the UK still recorded the highest number of COVID-related deaths in Europe, with more than 126,500 deaths.
In France, the use of the AstraZeneca vaccine is limited to people over 55 years of age. The family of a 38-year-old woman died of a cerebral thrombosis after vaccination. The family of this person filed a criminal lawsuit in Toulouse on Saturday, demanding homicide survey. .
She was one of four people in France who died of blood clotting within a few weeks of the AstraZeneca vaccine. The French National Agency for Drug Safety said that these cases and eight other cases of severe blood clotting are being investigated for survivors.
MHRA’s views on the relative benefits of vaccines have been endorsed by the European Medicines Agency. It said that the causal relationship between abnormal blood clots in people using the AstraZeneca vaccine “has not been proven, but it is possible,” and that the benefits of the vaccine outweigh the risk of side effects. The World Health Organization also urges countries to continue to use needles.
Adam Finn, a professor of pediatrics at the University of Bristol, said that with millions of stabs in the UK, blood clotting events are “extremely rare” and the decision is very simple.
He said: “In terms of minimizing the individual’s risk of serious illness or death, receiving a vaccine is the safest option.”
Angela Charlton of Paris contributed to this report.
Follow the Associated Press’s pandemic coverage at:
https://apnews.com/Understand the epidemic